Objective
During the FET NEBIAS we developed and clinically validated novel and effective restoration of sensory feedback from missing hand in upper-limb amputees. They felt natural sensations, used to ameliorate control and acceptance of prosthesis, and diminish phantom limb pain. The goal of SensAgain is to exploit these results commercially. In particular, we aim at verifying whether the innovation generated during NEBIAS could be used to provide valuable device for lower-limb amputees. We target them because they represent a larger population and suffer health problems related to absence of sensations from prosthesis. Indeed, because of the lack of sensory feedback from available prostheses, they suffer: falls due to unexpected perturbations, asymmetric walking and balance which induce arthritis, osteoporosis and back pain, higher power consumption (with occasional hearth failures), feeling the prosthesis as a foreign body (with consequent abandonment) and phantom pain. The first step we will perform is the validation with market stakeholders, which will enable the identification of the minimum features of a product accepted by the market, and the development of a strategic partnership with manufacturers, which will speed up the realization of a device compliant with CE standards. Then, we will define a clear market penetration strategy. Together with providing disabled persons with a unique device for rehabilitation, SensAgain will boost prosthetic adoption, with the consequent growth of the prosthetics and rehabilitation industries, which at its turn will create new jobs. Finally, by sharing the results with the members of the NEBIAS consortium, we will train academia personnel to structure their research mind-set toward the resolution of problems tailored by the market needs. On the other hand we will favor the process of creating innovation in industry, offering job positions to people with a background in research, in case of success of our translational project.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- natural sciences biological sciences neurobiology
- medical and health sciences clinical medicine rheumatology
- medical and health sciences clinical medicine physiotherapy
- medical and health sciences medical biotechnology implants
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.2. - EXCELLENT SCIENCE - Future and Emerging Technologies (FET)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.2.1. - FET Open
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
CSA - Coordination and support action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-FETOPEN-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
1003 LAUSANNE
Switzerland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.